Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · IEX Real-Time Price · USD
1.700
0.00 (0.00%)
At close: May 31, 2024, 4:00 PM
1.710
+0.010 (0.59%)
After-hours: May 31, 2024, 5:39 PM EDT
Lexicon Pharmaceuticals Market Cap
Lexicon Pharmaceuticals has a market cap or net worth of $614.54 million as of May 31, 2024. Its market cap has increased by 7.34% in one year.
Market Cap
614.54M
Enterprise Value
363.89M
1-Year Change
7.34%
Ranking
Category
Stock Price
$1.70
Market Cap Chart
Since April 7, 2000, Lexicon Pharmaceuticals's market cap has decreased from $890.90M to $614.54M, a decrease of -31.02%. That is a compound annual growth rate of -1.53%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 418.60M | - |
May 30, 2024 | 418.60M | 3.67% |
May 29, 2024 | 403.80M | -2.96% |
May 28, 2024 | 416.10M | 4.31% |
May 24, 2024 | 398.90M | 0.63% |
May 23, 2024 | 396.40M | -3.60% |
May 22, 2024 | 411.20M | - |
May 21, 2024 | 411.20M | -5.64% |
May 20, 2024 | 435.80M | - |
May 17, 2024 | 435.80M | -3.82% |
May 16, 2024 | 453.10M | -5.15% |
May 15, 2024 | 477.70M | 1.04% |
May 14, 2024 | 472.80M | 2.67% |
May 13, 2024 | 460.50M | 4.47% |
May 10, 2024 | 440.80M | -5.29% |
May 9, 2024 | 465.40M | 6.79% |
May 8, 2024 | 435.80M | - |
May 7, 2024 | 435.80M | -3.28% |
May 6, 2024 | 450.60M | 5.16% |
May 3, 2024 | 428.50M | 2.37% |
May 2, 2024 | 418.60M | 3.03% |
May 1, 2024 | 406.30M | 7.15% |
Apr 30, 2024 | 379.20M | -1.28% |
Apr 29, 2024 | 384.10M | -1.29% |
Apr 26, 2024 | 389.10M | 2.61% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Mind Medicine (MindMed) | 622.17M |
Varex Imaging | 620.66M |
Valneva SE | 619.23M |
iTeos Therapeutics | 618.42M |
Mineralys Therapeutics | 612.17M |
Weave Communications | 610.24M |
Dianthus Therapeutics | 608.62M |
PetIQ | 606.47M |